| Patents for C07C 317 - Sulfones; Sulfoxides (15,874) |
|---|
| 02/02/2006 | US20060025474 Bisphenyl compounds useful as vitamin D3 receptor agonists |
| 02/02/2006 | CA2573777A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 02/02/2006 | CA2570694A1 Amido compounds and their use as pharmaceuticals |
| 02/01/2006 | EP1620394A1 Method for crystallizing guanidinium salts |
| 02/01/2006 | EP1620391A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 02/01/2006 | EP1390339B1 Process for the preparation of 7-substituted 3-alkyl-3h-isobenzofuran-1-one derivatives |
| 02/01/2006 | CN1239495C Fungicides for control of take-all disease of plants |
| 02/01/2006 | CN1239478C 3,4-dibidro-1H-anphthalene derivatives used as high selectivity inhibitor of cyclooxygenase-2 |
| 01/31/2006 | US6992219 Invention provides five novel polymorphic forms of modafinil racemate called CRL 40476 form III, CRL 40476 form IV, CRL 40476 form V, CRL 40476 form VI, CRL 40476 form VII; treatment of sleep disorders |
| 01/31/2006 | US6992215 Thiol-based NAALADase inhibitors |
| 01/26/2006 | WO2005066119A3 Antibacterial 1-(4-mono-and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoropropanols and preparation thereof |
| 01/26/2006 | WO2005037205A3 Haloacetamide and azide substituted compounds and methods of use thereof |
| 01/26/2006 | US20060020146 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 01/26/2006 | US20060020039 E.g., 3-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)phenoxy)benzamidine; 7-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)-4-fluorophenoxy)1-aminoisoquinoline; and 3-(2-(4-[(2-aminosulfonyl)phenyl]phenylaminocarbonyl-4-chlorophenoxy)benzamidine; highly selective |
| 01/26/2006 | CA2574217A1 Diamine derivative, process of preparation thereof, and fungicide comprising diamine derivative as an active ingredient |
| 01/25/2006 | EP1619189A1 N-(3-acyl-2-hydroxyalkyl) cycloalkyl amide derivatives |
| 01/25/2006 | EP1619180A1 CaSR ANTAGONIST |
| 01/25/2006 | EP1618087A2 Antibacterial agents |
| 01/25/2006 | CN1238323C Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid compounds |
| 01/19/2006 | WO2006005909A1 Substituted acids for the treatment of respiratory diseases |
| 01/19/2006 | US20060014743 Methods of preventing bacterial infections with florfenicol-type antibiotics |
| 01/18/2006 | EP1616867A1 Hydroxycarboxylic acid derivatives |
| 01/18/2006 | EP1616865A1 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| 01/18/2006 | EP1616859A1 Substituted cyclohexyl carboxylic acid compounds |
| 01/18/2006 | EP1615899A1 Alpha-substituted carboxylic acids as ppar modulators |
| 01/18/2006 | EP1226819B1 Inhibitor for 20-hete-yielding enzyme |
| 01/18/2006 | EP1219595B1 O-anisamide derivatives |
| 01/18/2006 | CN1721400A Process for synthesizing 2-(diphenyl methyl sulfinyl) acetamide |
| 01/18/2006 | CN1721397A Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 01/18/2006 | CN1237041C Halogenated aromatic compound, its polymer, and proton conductive membrane containing same |
| 01/17/2006 | US6987112 Organic compound having cyano group and insecticides/miticides |
| 01/12/2006 | WO2006003923A1 Substituted benzene compound |
| 01/12/2006 | US20060009528 Cannabinoid receptor ligands |
| 01/12/2006 | US20060009525 Hydroxamic acids and acyl hydroxamines as NAALADase inhibitors |
| 01/12/2006 | US20060009511 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 01/11/2006 | EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/11/2006 | EP1272462B1 Semi-continuous method for producing 4,4'-dihydroxydiphenylsulfone |
| 01/11/2006 | CN1235925C Solid phase synthesing method of aldehyde, ketonic, oxime, amine and isohydroximic acid compound |
| 01/11/2006 | CN1235877C Substd. N-phenyl-2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivs. which elevate pyruvate dehydrogenase activity |
| 01/11/2006 | CN1235870C Novel use of phenyl hetero alkylamine derivatives |
| 01/10/2006 | US6984663 Cyclohexyl sulphones |
| 01/10/2006 | US6984645 Aryl carboxylic acids and tetrazoles for treating diabetes, especially type II diabetes |
| 01/10/2006 | CA2299760C Cyano containing oxamic acids and derivatives as thyroid receptor ligands |
| 01/05/2006 | US20060004062 Compounds for inhibiting insulin secretion and methods related thereto |
| 01/05/2006 | US20060002853 Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 01/04/2006 | EP1612205A1 Method for producing 3,3';-diallyl-4,4';-dihydroxydiphenylsulfone |
| 01/04/2006 | EP1611091A1 Novel compounds |
| 01/04/2006 | EP1611090A2 Cannabinoid receptor ligands |
| 01/04/2006 | EP1611086A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 01/04/2006 | EP1434762A4 4'-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/03/2006 | US6982353 C2-disubstituted indan-1-ol compounds, their derivatives, processes for their preparation, and their use as pharmaceuticals |
| 01/03/2006 | US6982348 for example, N[(1RS2SR)-2-(4-fluorophenyl)-2-hydroxy-1-[4-fluoromethyl)benzyl]ethyl]-6,7-dihydro-5H-benzo[a]cycloheptene-1-carboxamide; cholesteryl ester transfer protein inhibitory action; lipid-lowering agents |
| 12/29/2005 | WO2005123667A1 Substituted bicyclooctenes and their use as herbicides |
| 12/29/2005 | WO2005077122A3 Compounds and compositions as lxr modulators |
| 12/29/2005 | US20050288376 Bicyclyl or heterobicyclylmethanesulfonylanimo-substituted N-hydroxyformamides |
| 12/29/2005 | US20050288338 Amido compounds and their use as pharmaceuticals |
| 12/29/2005 | DE20122504U1 Kristallines und reines Modafinil Crystalline and pure modafinil |
| 12/29/2005 | DE102004027912A1 Substituierte Cyclopenten-Verbindungen Substituted cyclopentene compounds |
| 12/28/2005 | EP1299352B1 Compounds to treat alzheimer's disease |
| 12/28/2005 | CN1714075A Improved process for the preparation of 1,3-substituted indenes |
| 12/28/2005 | CN1714070A Vitamin d receptor modulators |
| 12/27/2005 | CA2256332C Substituted sulphonyl amino(thio)carbonyl compounds and their use as herbicides |
| 12/22/2005 | WO2005121078A2 Substituted cyclopentene compounds |
| 12/22/2005 | WO2005121077A1 Preparation and applications of polymer-supported halogenated benzoquinones as oxidative agents |
| 12/22/2005 | US20050282908 Substituted aminopropoxyaryl derivatives useful as agonists for LXR |
| 12/22/2005 | US20050282905 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient |
| 12/22/2005 | US20050282899 Resorcinol derivatives |
| 12/22/2005 | US20050282821 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| 12/21/2005 | EP1363878A4 Process for preparing sulfamoyl-substituted phenethylamine derivatives |
| 12/21/2005 | EP1265859B1 Amidino compounds useful as nitric oxide synthase inhibitors |
| 12/21/2005 | CN1232506C 4,4'-disubstituent diphenyl sulfon comprisnig di-sulfo group (salt) structure and its preparing method |
| 12/15/2005 | WO2005119315A2 Non-linear optically active molecules, their synthesis, and use |
| 12/15/2005 | WO2005118530A1 Triketone compounds, method for producing those and herbicide containing those |
| 12/15/2005 | US20050277665 e.g. 1,1,1-trifluoro-2-[4-(toluene-2-sulfonyl)phenyl]-propan-2-ol; hydroxysteroid dehydrogenases inhibitor; interconversion between cortisone and cortisol in humans; antidiabetic agent; obesity, insulin resistance, non-insulin -dependent diabetes |
| 12/15/2005 | DE4439128B4 Verfahren zur Reinigung von Natriumformaldehydsulfoxylat A process for the purification of sodium formaldehyde sulfoxylate |
| 12/15/2005 | CA2565705A1 Non-linear optically active molecules, their synthesis, and use |
| 12/14/2005 | EP1604212A2 Modulators of the g protein-coupled formyl peptide receptor-like 2 and their therapeutic use against cell death-related disorders |
| 12/14/2005 | EP1603918A1 Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof |
| 12/14/2005 | EP1603867A2 Process for preparing benzhydrylthioacetamide |
| 12/14/2005 | EP1440052B1 Benzamide derivatives as antagonists of orexin receptors |
| 12/14/2005 | CN1708478A P-(sulfonyl)-aryl and heteroaryls amines |
| 12/14/2005 | CN1708477A Recording material comprising diphenyl sulfone derivative and novel diphenyl sulfone derivative compound |
| 12/14/2005 | CN1231465C Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament |
| 12/13/2005 | USRE38921 have strong and selective leukotriene antagonist activity, and are useful for prevention and treatment of allergic diseases such as bronchial asthma |
| 12/13/2005 | US6974886 Removing trihydroxytriphenylsulfone and color impurities without altering the isomeric composition of 4,4'-DDS and 2,4'-DDS; dissolving in aqueous solvent, adjusting pH, and precipitation |
| 12/13/2005 | US6974876 Method for preparing intermediates useful in synthesis of retroviral protease inhibitors |
| 12/13/2005 | US6974840 Therapeutic agents |
| 12/13/2005 | US6974828 3-((2-((3-((Amino(imino)methyl)amino)benzoyl)amino)phenyl)sulf anyl)- 3-(3-pyridinyl)propanoic acid, for example; angiogenic inhibitors; antitumor, -carcinogenic, -metastatic, -diabetic, -arthritic and inflammatory agents; bone disorders |
| 12/08/2005 | US20050272957 Process for preparing dibasic salts of bisphenols |
| 12/08/2005 | US20050272956 Process for producing high-purity 4,4'-dihydroxydiphenyl sulfone |
| 12/08/2005 | US20050272955 Substituted cyclopentene compounds |
| 12/08/2005 | US20050272931 Vanilloid receptor ligands and their use in treatments |
| 12/08/2005 | US20050272638 Improved bioavailability; for oral and intracolonic administration |
| 12/08/2005 | US20050272036 Ketones |
| 12/07/2005 | EP1602369A2 Bupropion Metabolites and Methods of their Synthesis and Use |
| 12/07/2005 | EP1601644A1 Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors |
| 12/07/2005 | EP1601642A2 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 12/07/2005 | EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 12/07/2005 | EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 12/06/2005 | US6972340 For therapy of diabetes, obesity, autoimmune disorders, acute and chronic inflammatory disorders, osteoporosis, cancer, malignant disorders |